menu
    • menu

    Company profile for Lucy Therapeutics

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Lucy Therapeutics is leading the change in how we think about mitochondria and the intersecting pathways that play critical roles in human health and disease. Focused initially on diseases of the central nervous system (CNS), such as Parkinson’s disease or Rett syndrome, our vision is to create a world in which mitochondrial-involved diseases can be halted the moment they are diagnosed.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Lucy TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Cambridge, Massachusetts
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.lucytherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/lucy-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/lucytherapeutix

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lucy Therapeutics Appoints Kim Drapkin as Board Chair
    Lucy Therapeutics Appoints Kim Drapkin as Board Chair

    15 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241015322008/en

    BUSINESSWIRE
    15 Oct 2024
    Share Share
    LucyTx announces additional $12.5m research funding for neurological diseases
    LucyTx announces additional $12.5m research funding for neurological diseases

    11 Jun 2024

    // PHARMA TIMES

    https://pharmatimes.com/news/lucytx-announces-additional-12-5m-research-funding-for-neurological-diseases/

    PHARMA TIMES
    11 Jun 2024
    Share Share
    Lucy Therapeutics: Funding For Alzheimer's, Parkinson's Treatments
    Lucy Therapeutics: Funding For Alzheimer's, Parkinson's Treatments

    28 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240528977106/en

    BUSINESSWIRE
    28 May 2024
    Share Share
    Lucy Therapeutics Appoints Christopher J. Winrow as Chief Scientific Officer
    Lucy Therapeutics Appoints Christopher J. Winrow as Chief Scientific Officer

    29 Mar 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230329005245/en

    BUSINESSWIRE
    29 Mar 2023
    Share Share
    Lucy Therapeutics Appoints Julia Gaebler, Ph.D., as Chief Business Officer
    Lucy Therapeutics Appoints Julia Gaebler, Ph.D., as Chief Business Officer

    15 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221115005644/en

    BUSINESSWIRE
    15 Nov 2022
    Share Share
    Lucy Therapeutics Appoints Julia Gaebler as CBO
    Lucy Therapeutics Appoints Julia Gaebler as CBO

    15 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221115005644/en/Lucy-Therapeutics-Expands-Leadership-Team-with-Appointment-of-Julia-Gaebler-Ph.D.-as-Chief-Business-Officer

    BUSINESSWIRE
    15 Nov 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search